BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16007623)

  • 21. Assessment of simple movements reflects impairment in Huntington's disease.
    Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
    Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging in Huntington's disease.
    Sethi KD
    Mov Disord; 1991; 6(2):186. PubMed ID: 1829138
    [No Abstract]   [Full Text] [Related]  

  • 23. [The advances in research on phosphorylation of polyglutamine disease].
    Zhou YF; Jiang H; Tang JG; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Juvenile onset Huntington's disease: correlation with progressive myoclonus epilepsy].
    Sato K; Abe K
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):198-200. PubMed ID: 12483860
    [No Abstract]   [Full Text] [Related]  

  • 25. Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation.
    Bech S; Petersen T; Nørremølle A; Gjedde A; Ehlers L; Eiberg H; Hjermind LE; Hasholt L; Lundorf E; Nielsen JE
    Parkinsonism Relat Disord; 2010 Jan; 16(1):12-5. PubMed ID: 19595623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.
    Kassubek J; Juengling FD; Kioschies T; Henkel K; Karitzky J; Kramer B; Ecker D; Andrich J; Saft C; Kraus P; Aschoff AJ; Ludolph AC; Landwehrmeyer GB
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):213-20. PubMed ID: 14742591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychotic syndrome in chorea Huntington].
    Känzig S; Eichorn M
    Psychiatr Prax; 2003 Jul; 30(5):286-7. PubMed ID: 12947934
    [No Abstract]   [Full Text] [Related]  

  • 28. Huntington's disease - neuropathology.
    Vonsattel JP; Keller C; Cortes Ramirez EP
    Handb Clin Neurol; 2011; 100():83-100. PubMed ID: 21496571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between CAG repeat length and clinical progression in Huntington's disease.
    Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
    Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rigid forms of Huntington's disease (study of a family with an anatomo-clinical case)].
    Delmas-Marsalet P; Bourgeois M; Vital C; Fontanges X
    Rev Neurol (Paris); 1968 Apr; 118(4):273-83. PubMed ID: 4235068
    [No Abstract]   [Full Text] [Related]  

  • 31. CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients.
    Stevanin G; Camuzat A; Holmes SE; Julien C; Sahloul R; Dodé C; Hahn-Barma V; Ross CA; Margolis RL; Durr A; Brice A
    Neurology; 2002 Mar; 58(6):965-7. PubMed ID: 11914418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters.
    Roth J; Klempìi J; Jech R; Zidovská J; Uhrová T; Doubek P; Ulmanová O; Brozová H; Volfová M; Serranová T; Ruzicka E
    Funct Neurol; 2005; 20(3):127-30. PubMed ID: 16324236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monozygotic twins suffering from Huntington's disease show different cognitive and behavioural symptoms.
    Gómez-Esteban JC; Lezcano E; Zarranz JJ; Velasco F; Garamendi I; Pérez T; Tijero B
    Eur Neurol; 2007; 57(1):26-30. PubMed ID: 17108691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain structure in preclinical Huntington's disease.
    Paulsen JS; Magnotta VA; Mikos AE; Paulson HL; Penziner E; Andreasen NC; Nopoulos PC
    Biol Psychiatry; 2006 Jan; 59(1):57-63. PubMed ID: 16112655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A four-year prospective study of cognitive functioning in Huntington's disease.
    Ward J; Sheppard JM; Shpritz B; Margolis RL; Rosenblatt A; Brandt J
    J Int Neuropsychol Soc; 2006 Jul; 12(4):445-54. PubMed ID: 16981596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat.
    Winkler C; Gil JM; Araújo IM; Riess O; Skripuletz T; von Hörsten S; Petersén A
    Brain Res Bull; 2006 Apr; 69(3):306-10. PubMed ID: 16564426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosocial effects of predictive testing for Huntington's disease.
    Hayden MR; Bombard Y
    Adv Neurol; 2005; 96():226-39. PubMed ID: 16383222
    [No Abstract]   [Full Text] [Related]  

  • 38. Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging.
    Loy CT; Sweeney MG; Davis MB; Wills AJ; Sawle GV; Lees AJ; Tabrizi SJ
    Mov Disord; 2005 Nov; 20(11):1521-3. PubMed ID: 16037935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical study of patients with genetically confirmed Huntington's disease from India.
    Murgod UA; Saleem Q; Anand A; Brahmachari SK; Jain S; Muthane UB
    J Neurol Sci; 2001 Sep; 190(1-2):73-8. PubMed ID: 11574110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Juvenile Huntington's disease: report of one case.
    Sue WC; Hwu WL; Chen CY
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1998; 39(5):342-5. PubMed ID: 9823684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.